On 21 february 2023 leica biosystems received a complaint that the customer experienced suboptimal tissue processing on their histocore pegasus plus.On 03 march 2023 the customer informed leica biosystems, that as a result, 1 tissue skin sample has not been diagnosed.
|
The investigation revealed the following: the instrument logs were analyzed by the lbs senior quality engineer and no instrument error was detected during the processing steps related to the damaged tissue.Furthermore, the affected instrument was sent back to nussloch for an additional investigation with result, that no malfunction of the instrument has been found.The incident was user related due to an incorrect usage of the processing protocol and carryover settings, because the tissues and biopsies were processed together with an overnight protocol.The carryover setting is a setting for a protocol, not for a specific run, so it must be set to the average carryover value for runs that use that protocol.The carryover is dependent on the types of cassettes and other small-tissue carriers used: biopsy pads, paper or tissue inserts, mini cassettes, biopsy cassettes, etc.It also depends on the proportion of these in each run.Therefore, the protocol setup depends on the processed tissues, and therefore different protocol and carryover settings need to be selected.A customer facing letter will be sent out to the customer with recommendation, to consider the carryover setting and to use the recommended accordingly the protocol for standard biopsy and small specimen as defined in the instruction for use (ifu).
|